Our History

1994 1995 1997 1999 2000 2002 2004 2005 2006 2008 2009 2010 2011 2012 2013 2014 2015 2016
  • 1994

    Estabilishment of the CinnaGen

    CinnaGen Co. was established in 1994 by a group of young Iranian scientists.

     

  • 1995

    Production and Marketing of Taq DNA polymerase

    CinnaGen Co. is the 1st Iranian Taq DNA polymerase manufacturer in the MENA region.

  • 1997

    Production and Marketing of Molecular Diagnostic kits(PCR-based technology)

  • 1999

    Production of ABO grouping kit-entering the area of diagnostic monoclonal antibodies production

    CinnaGen is the 1st Monoclonal Antibody producer in MENA region.

     

  • 2000

    Pharmaceutical Synthetic Peptides Production

    Production of GnRH-entering the area of pharmaceutical synthetic peptides production

     

  • 2000

    ISO Granted

    ISO 9001:1994 Granted

  • 2002

    New Biotechnology Services

    Primer synthesis service

    DNA sequencing service

    Production of Restriction enzymes

  • 2004

    Construct SD1

    Inauguration of manufacturing-plant in Simindasht-Karaj (record breaking construction in 10 months)

    Production of Busereline-Acetate

  • 2005

    Pharmaceutical Era

    Starting Clinical Trial of CinnoVex (rec Hu-IFN beta 1a)

    Production of active pharmaceutical ingredient of rec Hu-erythropoietin beta

    ISO 9001:2000 Granted

  • 2006

    First Recombinant Drug, Now in Market

    Launching CinnoVex in the local market as the second producer in the world after Biogen-Idec

    GMP Certificate granted by MOH of I.R.Iran

  • 2006

    CinnoVex Launch

    CinnaGen get release license of CinnoVex (interferon Beta- 1a) from Iranian FDO.

  • 2008

    Powering up

    Starting Clinical Trial of Betapoietin and ReciGen(rec Hu-IFN beta 1a-44 microgram)

    Cooperation with Dr. Reddy-India for Technology transfer of Rituximab

    rec Hu-FSH in the pipeline rec Hu-PTH in the pipeline

    ISO 13485:2003 and 9001:2008 Granted

  • 2008

    High Dose Achieved

    Launching ReciGen(rec Hu-IFN beta 1a-44microgerams)

    Production of Reditux™(Rituximab) therapeutic monoclonal antibody

    Rec Hu-PEG-GCSF in the pipeline

  • 2009

    ReciGen Launch

    CinnaGen got release license of ReiGen (interferon Beta- 1a) from Iranian FDO.

  • 2010

    Beyond the Boundaries

    Registration of CinnoVex™ in Russia, Syria and Armenia

    Launching Betapoietin (rec Hu-EPO beta)

    Starting Clinical Trial of CinnoPar (rec Hu-PTH)

  • 2011

    New Building

    Commencing the construction of a new production facility SD2.

    Launching Reditux™ (Rituximab)as the first Monoclonal antibody produced in Iran

    Launching CinnaFact (Buserelin Acetate)

  • 2011

    CinnaFact Launch

    CinnaGen got release license of CinnaFact (Buserelin) from Iranian FDO.

  • 2012

    GMP based on EMA Regulations

    Commencing the construction of a new warehouse facility SD3 (Simin dasht-3)

    Qualification and running of new state of the art GMP facility (SD-2) based on EMA Regulations.

    Registration of ReciGen® in Syria

    Registration of CinnoVex™ in Azerbaijan

  • 2013

    Expanding our basket

    Launching Cinnal f® (Follitropin alfa)as the first follitropin biosimilar produced in Iran

    Launching CinnoPar® (Teriparatide) as the first parathyroid hormone (1-34) biosimilar produced in Iran

    Launching CinnaPoietin® (rec Hu-EPO beta)

    Launching PegaGen® (Peg-filgrastim) as the first Pegylated filgrastim biosimilar produced in Iran

    Launching Recigen in Syria

  • 2013

    CinnoPar Launch

    CinnaGen got release license of CinnoPar (Parathyroid Hormone) from Iranian FDO.

  • 2013

    Cinnal-f Launch

    CinnaGen got release license of Cinnal-f (Follitropin alfa) from Iranian FDO.

  • 2014

    PegaGen Launch

    CinnaGen got release license of PegaGen (Pegylated Filgrastim) from Iranian FDO.

  • 2014

    CinnaPoietin Launch

    CinnaGen got release license of CinnaPoietin (Erythropoietin) from Iranian FDO.

  • 2015

    CinnoMer Launch

    CinnaGen got release license of CinnoMer (Glatiramer) from Iranian FDO.

  • 2015

    CinnoTec Launch

    CinnaGen got release license of CinnoTec (Dimethyl Fumarate) from Iranian FDO.

  • 2016

    CinnoRA Launch

    CinnaGen got release license of CinnoRA(Adalimumab)from Iranian FDO